HLA-antigens and the prognosis of multiple sclerosis
β Scribed by Sigrid Poser; G. Ritter; H. J. Bauer; H. Grosse-Wilde; E. K. Kuwert; N. E. Raun
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 143 KB
- Volume
- 225
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
β¦ Synopsis
The histocompatibility pattern of 160 patients with multiple sclerosis (MS) living in the epidemiological area of Southern Lower Saxony was determined and compared to a control population. The only significant difference was the more frequent occurrence of DW2 in the patient group (44% vs. 21%). Taking a progression index (grade of disability divided by the duration of the disease) as a measure for prognosis no difference could be found between the DW2 positive and the DW2 negative patients. The reason why we could not confirm the worse prognosis for DW2 positive patients found by Jersild et al. (1973) and Raun et al. (1980) remains to be investigated.
π SIMILAR VOLUMES
The HLA-A, -B, -C and -D were determined in 200 multiple sclerosis (MS) patients, 64 of whom underwent a CSF examination. Their frequencies were correlated with the rate of disease progression and with factors thought to influence disease progression, including onset age, type of clinical course and
Patients with multiple sclerosis (MS) from the two Montreal MS clinics, were divided into two groups: one group of 61 patients (MS type I) who had no clinical history of susceptibility to recurrent respiratory tract infections and a second group of 58 patients (MS type II) who had persistent suscept